Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofi E Eriksson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Reviews. Cancer|December 16, 2017
Targeting mutant p53 for efficient cancer therapyVladimir J N Bykov, Sofi E Eriksson, Julie Bianchi, et al.
Journal of Molecular Cell Biology|March 21, 2019
p53 as a hub in cellular redox regulation and therapeutic target in cancerSofi E Eriksson, Sophia Ceder, Vladimir J N Bykov, et al.
Free Radical Biology & Medicine|May 27, 2008
Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanatesKristin K Brown, Sofi E Eriksson, Elias S J Arnér, et al.
Free Radical Biology & Medicine|September 22, 2009
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacySofi E Eriksson, Stefanie Prast-Nielsen, Emilie Flaberg, et al.
Biochimica Et Biophysica Acta|March 11, 2014
Serum thioredoxin reductase levels increase in response to chemically induced acute liver injuryKang Sun, Sofi E Eriksson, Yanping Tan, et al.
Cell Death & Disease|July 16, 2021
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cellsSophia Ceder, Sofi E Eriksson, Ying Yu Liang, et al.
EMBO Molecular Medicine|December 14, 2020
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell deathSophia Ceder, Sofi E Eriksson, Emarndeena H Cheteh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Reviews. Cancer|December 16, 2017
Targeting mutant p53 for efficient cancer therapyVladimir J N Bykov, Sofi E Eriksson, Julie Bianchi, et al.
Journal of Molecular Cell Biology|March 21, 2019
p53 as a hub in cellular redox regulation and therapeutic target in cancerSofi E Eriksson, Sophia Ceder, Vladimir J N Bykov, et al.
Free Radical Biology & Medicine|May 27, 2008
Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanatesKristin K Brown, Sofi E Eriksson, Elias S J Arnér, et al.
Free Radical Biology & Medicine|September 22, 2009
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacySofi E Eriksson, Stefanie Prast-Nielsen, Emilie Flaberg, et al.
Biochimica Et Biophysica Acta|March 11, 2014
Serum thioredoxin reductase levels increase in response to chemically induced acute liver injuryKang Sun, Sofi E Eriksson, Yanping Tan, et al.
Cell Death & Disease|July 16, 2021
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cellsSophia Ceder, Sofi E Eriksson, Ying Yu Liang, et al.
EMBO Molecular Medicine|December 14, 2020
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell deathSophia Ceder, Sofi E Eriksson, Emarndeena H Cheteh, et al.
Pageof 1